VisionGate, Inc. Announced Five Abstracts Describing its Cell-CT™ System for 3D Cellular Imaging

VisionGate, Inc. presented abstracts describing its Cell-CT system and the Lung Cell Evaluation Device test (LuCED), for early detection of lung cancer, at the 13th World Conference on Lung Cancer, held in San Francisco between July 31 and August 4.